Skip to Content
Robert R Redfield III, MD

Contact Dr. Redfield

E-mail:
redfield@surgery.wisc.edu

Phone:
(608) 263-0388

Mail:
600 HIGHLAND AVE
MC 7375
MADISON, WI 53792-0001

Robert R Redfield III, MD

Assistant Professor
Division of Transplantation

Education

  • MD, Magna Cum Laude, University of Maryland School of Medicine, Baltimore, MD, 2006
  • Internship, Hospital of the University of Pennsylvania, Philadelphia, PA, 2007
  • Transplant Immunobiology Research Fellowship, Harrison Department of Surgical Research, University of Pennsylvania, Philadelphia, PA, 2011
  • Surgery Residency, Hospital of the University of Pennsylvania, Philadelphia, PA, 2013
  • Transplantation Fellowship, University of Wisconsin Hospital and Clinics, Madison, WI, 2013-2015

Clinical Specialties

Dr. Redfield is certified by the American Board of Surgery and is a ASTS and UNOS certified transplant surgeon. He specializes in pancreatic, islet cell, and multi-organ transplants as well as vascular access.

Dr. Redfield provides a wide range of services including Kidney Transplant, Laparoscopic Donor Nephrectomy, Pancreas Transplant, Robotic Donor Nephrectomy, and "Scarless" Single-Port Laparoscopic Donor Nephrectomy.

Research Interests

Dr. Redfield’s research interests are centered on developing novel strategies to improve long-term allograft survival.

Recent Publications
  • Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers.
    Scalea JR, Redfield RR, Foley DP
    Liver Transpl. 2016 Sep; 22(9):1197-204.
    [PubMed ID: 27314220]
    More Information
  • The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients.
    Redfield RR, Scalea JR, Zens TJ, Mandelbrot DA, Leverson G, Kaufman DB, Djamali A
    Nephrol. Dial. Transplant. 2016 Jul 6.
    [PubMed ID: 27387475]
    More Information
  • Pancreas transplantation in older patients is safe, but patient selection is paramount.
    Scalea JR, Redfield RR, Arpali E, Leverson G, Sollinger HW, Kaufman DB, Odorico JS
    Transpl. Int. 2016 Jul; 29(7):810-8.
    [PubMed ID: 26859581]
    More Information
  • Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.
    Eby BC, Redfield RR, Ellis TM, Leverson GE, Schenian AR, Odorico JS
    Transplantation 2016 May; 100(5):1103-10.
    [PubMed ID: 26950720, PMC ID: 4846496]
    More Information
  • Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria.
    Redfield RR, Ellis TM, Zhong W, Scalea JR, Zens TJ, Mandelbrot D, Muth BL, Panzer S, Samaniego M, Kaufman DB, Astor BC, Djamali A
    Hum. Immunol. 2016 Apr; 77(4):346-52.
    [PubMed ID: 26867813]
    More Information
  • When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States.
    Scalea JR, Redfield RR, Rizzari MD, Bennett R, Anderson ME, Anderson JE, Kaufman DB, Sollinger HW, Fernandez LA, D'Alessandro AM, Mezrich J
    Ann. Surg. 2016 Feb; 263(2):211-6.
    [PubMed ID: 26181480]
    More Information
  • Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy.
    Redfield RR, McCune KR, Rao A, Sadowski E, Hanson M, Kolterman AJ, Robbins J, Guite K, Mohamed M, Parajuli S, Mandelbrot DA, Astor BC, Djamali A
    Transpl. Int. 2016 Feb; 29(2):167-72.
    [PubMed ID: 26284692]
    More Information
  • Pancreas Transplantation in the Modern Era.
    Redfield RR, Rickels MR, Naji A, Odorico JS
    Gastroenterol. Clin. North Am. 2016 Mar; 45(1):145-66.
    [PubMed ID: 26895686]
    More Information
  • Predictors and outcomes of delayed graft function after living-donor kidney transplantation.
    Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A, Astor BC, Mohamed M
    Transpl. Int. 2016 Jan; 29(1):81-7.
    [PubMed ID: 26432507]
    More Information
  • Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR, Wilson NA, Huang G, Redfield RR, Zhong W, Djamali A
    Transplantation 2015 Sep; 99(9):1785-95.
    [PubMed ID: 25919767]
    More Information

webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System